COVID‐19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatments-Reference-Cited by-同舟云学术

COVID‐19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatments

Published:2020-08-20 Issue:3 Volume:76 Page:887-892
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Heffler Enrico¹²^ORCID,Detoraki Aikaterini³,Contoli Marco⁴,Papi Alberto⁴,Paoletti Giovanni¹²,Malipiero Giacomo¹,Brussino Luisa⁵,Crimi Claudia⁶,Morrone Daniela⁷,Padovani Marianna⁴,Guida Giuseppe⁸,Gerli Alberto Giovanni⁹^ORCID,Centanni Stefano¹⁰,Senna Gianenrico¹¹,Paggiaro Pierluigi¹²,Blasi Francesco¹³¹⁴,Canonica Giorgio Walter¹²,

Affiliation:

1. Personalized Medicine, Asthma and Allergy Humanitas Clinical and Research Center IRCCS Rozzano Italy

2. Department of Biomedical Sciences Humanitas University Pieve Emanuele Italy

3. Department of Internal Medicine Clinical Immunology, Clinical Pathology and Infectious Disease Azienda Ospedaliera Universitaria Federico II Napoli Italy

4. Department of Morphology, Surgery and Experimental Medicine University of Ferrara Ferrara Italy

5. Department of Medical Sciences AO Ordine Mauriziano Umberto I University of Torino Torino Italy

6. Department of Clinical and Experimental Medicine University of Catania Catania Italy

7. Severe Asthma Network in Italy (SANI) Infrastructure Milano Italy

8. Allergy and Pneumology Unit A.O. S. Croce e Carle Cuneo Italy

9. Management Engineering Tourbillon Tech srl Padova Italy

10. Respiratory Unit Department of Health Sciences ASST Santi Paolo e Carlo San Paolo Hospital University of Milano Milano Italy

11. Asthma Center and Allergy Unit Verona University Hospital Verona Italy

12. Department of Surgery, Medicine, Molecular Biology and Critical Care University of Pisa Pisa Italy

13. Internal Medicine Department Respiratory Unit and Adult Cystic Fibrosis Center Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico Milano Italy

14. Department of Pathophysiology and Transplantation University of Milano Milano Italy

Funder

Sanofi Genzyme

AstraZeneca

Novartis

GlaxoSmithKline

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/all.14532

Reference9 articles.

1. Civil Protection Department of the Italian Government.http://opendatadpc.maps.arcgis.com/apps/opsdashboard/index.html#/b0c68bce2cce478eaac82fe38d4138b1(Accessed the 18th June 2020).

2. Role of viral respiratory infections in asthma and asthma exacerbations

3. Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?

4. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma

5. The Severe Asthma Network in Italy: Findings and Perspectives

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bronchial Asthma and COVID-19: Etiology, Pathological Triggers, and Therapeutic Considerations;Pathophysiology;2024-05-27

2. Association between allergic conditions and COVID-19 susceptibility and outcomes;Annals of Allergy, Asthma & Immunology;2024-05

3. COVID-19 Clinical Features and Outcome in Italian Patients Treated with Biological Drugs Targeting Type 2 Inflammation;Life;2024-03-13

4. COVID-19 and Its Impact on Common Diseases in the Allergy Clinics;The Journal of Allergy and Clinical Immunology: In Practice;2023-11

5. The Effect of Biologic Therapy in Severe Asthmatics and ER Admissions During COVID-19: A Retrospective Study;Journal of Asthma and Allergy;2023-08